SODIUM IODIDE I-123 - Generic Drug Details

What are the generic drug sources for sodium iodide i-123 and what is the scope of patent protection?

Sodium iodide i-123 is the generic ingredient in one branded drug marketed by Cardinal Health 418, Curium, and Ge Healthcare, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for SODIUM IODIDE I-123

US Patents:	0
Tradenames:	1
Applicants:	3
NDAs:	4
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	19
DailyMed Link:	SODIUM IODIDE I-123 at DailyMed

Recent Clinical Trials for SODIUM IODIDE I-123

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National University of Malaysia	PHASE2
Stryker Endoscopy	Phase 4
University Health Network, Toronto	Phase 4

See all SODIUM IODIDE I-123 clinical trials

US Patents and Regulatory Information for SODIUM IODIDE I-123

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	SODIUM IODIDE I 123	sodium iodide i-123	SOLUTION;ORAL	017630-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Cardinal Health 418	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	018671-002	May 27, 1982	AA	RX	Yes	Yes
Curium	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	071909-001	Feb 28, 1989	AA	RX	No	No
Cardinal Health 418	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	018671-003	May 27, 1982		DISCN	No	No
Ge Healthcare	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	017630-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Curium	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	071910-001	Feb 28, 1989	AA	RX	No	No
Cardinal Health 418	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	018671-001	May 27, 1982	AA	RX	Yes	Yes